Serina Therapeutics, Inc.
SER- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001708599
In the last 90 days, Serina Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; 27 institutions reported holding it in 13F filings for Q2 2026, worth $2.73M in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Serina Therapeutics, Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 25 | 22 | −3 |
| Shares | 461.8K | 429.6K | −32.2K (−7.0%) |
| Value | $2.48M | $821.8K | −$1.65M (−66.8%) |
New holders (0)
Institutions that held Serina Therapeutics, Inc. at the end of Q4 2025 but not at the end of Q3 2025.
None.
Sold out (3)
Institutions that held Serina Therapeutics, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Citigroup Inc | 2,323 | $12.5K |
| Advisory Services Network, LLC | 14 | $75 |
| JPMorgan Chase & Co | 10 | $54 |